Trial Profile
Effects of 5-aminolevulinic acid on cognitive functions in normal subjects using fMRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cancer; Skin cancer
- Focus Pharmacodynamics
- 20 Nov 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 19 Dec 2012 New trial record